MedTrace Logo

Mass Spectral Fingerprinting in Lung Cancer

NCT02781857 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 393

Last updated 2025-03-20

No results posted yet for this study

Summary

To answer the question whether a disease specific profile of breath in patients with lung cancer can be detected by an untargeted metabolomic study using exhaled breath analysis by mass spectrometry.

Conditions

Interventions

OTHER

No intervention

Sponsors & Collaborators

  • Swiss Federal Institute of Technology

    collaborator OTHER

  • University of Zurich

    lead OTHER

Principal Investigators

  • Malcolm Kohler, Prof. MD · University of Zurich

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2024-07-31
Completion
2025-03-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02781857 on ClinicalTrials.gov